A Neuroendocrine Tumor Specialty Center in New Orleans’ (NOLANETS) Response to Patient Care During the COVID‐19 Pandemic

This commentary outlines the steps taken by the New Orleans Louisiana Neuroendocrine Tumor Specialists to minimize the risk of patient exposure to SARS‐CoV‐2 but to continue to provide safe, high‐quality care during the COVID‐19 pandemic.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2020-07, Vol.25 (7), p.548-551
Hauptverfasser:	Ramirez, Robert A., Bren‐Mattison, Yvette, Thiagarajan, Ramcharan, Boudreaux, J. Philip, Marsala, Andrew J., Ryan, Pamela, Maluccio, Mary A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - pathogenicity Cancer Care Facilities - organization & administration Cancer Care Facilities - standards Commentaries Continuity of Patient Care - organization & administration Continuity of Patient Care - standards Coronavirus Infections - epidemiology Coronavirus Infections - prevention & control Coronavirus Infections - transmission Coronavirus Infections - virology COVID-19 Humans Infection Control - organization & administration Infection Control - standards Medical Oncology - organization & administration Medical Oncology - standards Neuroendocrine tumors Neuroendocrine Tumors - therapy New Orleans - epidemiology New Orleans Louisiana Neuroendocrine Tumor Specialists Pandemics - prevention & control Pneumonia, Viral - epidemiology Pneumonia, Viral - prevention & control Pneumonia, Viral - transmission Pneumonia, Viral - virology Practice Guidelines as Topic SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This commentary outlines the steps taken by the New Orleans Louisiana Neuroendocrine Tumor Specialists to minimize the risk of patient exposure to SARS‐CoV‐2 but to continue to provide safe, high‐quality care during the COVID‐19 pandemic.
ISSN:	1083-7159 1549-490X
DOI:	10.1634/theoncologist.2020-0279